Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Haizao Xiaoyu Decoction is a classic multi-herb formula in traditional Chinese medicine (TCM), historically used for over 500 years primarily to treat goiter and other thyroid-related diseases. The formula is notable for containing both Glycyrrhiza (licorice root) and Sargassum (seaweed), which are traditionally considered incompatible in TCM but have demonstrated synergistic effects in this context. The main mechanism of action involves inhibition of angiogenesis and cell proliferation in goiter tissue, primarily through suppression of the PI3K-Akt signaling pathway. Modern pharmacological studies confirm its efficacy against goiter, with additional benefits such as antioxidative activity and modulation of thyroid hormone levels[1][3][10]. The formula contains multiple active compounds including glycyrrhizinic acid, liquiritin, nobiletin, osthole, 6-gingerol, honokiol among others[4][6]. It is typically prepared as a water-based herbal decoction.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on haizao xiaoyu decoction.